Breaking News Instant updates and real-time market news.

FDC

First Data

$17.83

-0.18 (-1.00%)

16:24
11/14/18
11/14
16:24
11/14/18
16:24

First Data initiated with an Overweight at Barclays

Barclays analyst Ramsey El-Assal initiated First Data with an Overweight and $24 price target.

  • 12

    Dec

  • 03

    Mar

FDC First Data
$17.83

-0.18 (-1.00%)

11/08/18
SUSQ
11/08/18
DOWNGRADE
Target $77
SUSQ
Neutral
Square downgraded to Neutral on valuation, CFO vacancy at Susquehanna
As reported previously, Susquehanna analyst James Friedman downgraded Square (SQ) to Neutral from Positive. The analyst cited valuation and the lack of a CFO at the company. While he sees Square taking about ten billion of cumulative revenue share from incumbent merchant acquirers, ISOs and ISVs, he would await a better re-entry point pending management visibility, Friedman tells investors. In the meantime, Friedman suggests investors look at First Data (FDC) instead, stating that Clover is generally performing as well as Square's payments products while the stock's discount to Square "seems compelling." Friedman maintained his $77 price target on Square shares.
11/06/18
COWN
11/06/18
NO CHANGE
Target $28
COWN
Outperform
First Data weakness a buying opportunity, says Cowen
Cowen analyst George Mihalos recommended investors take advantage of the overdone weakness in First Data shares. He expects the stock to recoup most of its downward move over the near-term, citing the reset of its GBS growth expectations, on-track deleveraging, and current valuation. Mihalos has an Outperform rating and $28 price target on First Data shares.
11/05/18
SPHN
11/05/18
NO CHANGE
Target $25
SPHN
Overweight
First Data price target lowered to $25 from $30 at Stephens
Stephens analyst Brett Huff lowered his price target for First Data to $25 from $30 following quarterly results, but reiterated an Overweight rating on the shares saying the selloff in the stock is "overdone." The analyst believes it may take a quarter or two for the market to recognize First Data's value.
10/30/18
WELS
10/30/18
NO CHANGE
Target $30
WELS
Outperform
First Data valuation compelling following selloff, says Wells Fargo
Wells Fargo analyst Timothy Willi says that despite First Data's Q3 miss and lowered 2018 guidance, he believes its underlying business performance remains "solid" and would argue shares valuation is "compelling." Although it is never good to see a miss and lower, it is entirely attributable to a worsening FX environment and two divestitures in GFS, he contends. Willi reiterates an Outperform rating and $30 price target on the stock.

TODAY'S FREE FLY STORIES

SOLY

Soliton

$11.07

0.63 (6.03%)

08:03
08/20/19
08/20
08:03
08/20/19
08:03
Hot Stocks
Soliton announces results from preclinical studies of RAP treatment »

Soliton announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$2.71

(0.00%)

08:03
08/20/19
08/20
08:03
08/20/19
08:03
Hot Stocks
Mersana Therapeutics intitiates expansion portion of Phase 1 study of XMT-1536 »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGR

Eiger BioPharmaceuticals

$10.43

0.16 (1.56%)

08:02
08/20/19
08/20
08:02
08/20/19
08:02
Hot Stocks
Eiger BioPharmaceuticals receives FDA BTD for for peginterferon lambda »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIQT

LiqTech

$6.44

-0.81 (-11.17%)

08:02
08/20/19
08/20
08:02
08/20/19
08:02
Hot Stocks
LiqTech announces SPA to acquire BS Plastic »

LiqTech International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 12

    Sep

CACI

CACI

$209.74

1.42 (0.68%)

08:01
08/20/19
08/20
08:01
08/20/19
08:01
Upgrade
CACI rating change  »

CACI upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VST

Vistra Energy

$23.68

-0.02 (-0.08%)

08:00
08/20/19
08/20
08:00
08/20/19
08:00
Hot Stocks
Vistra Energy to acquire Ambit Energy for $475M »

Vistra Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

CNHI

CNH Industrial

$9.37

0.555 (6.30%)

08:00
08/20/19
08/20
08:00
08/20/19
08:00
Options
CNH Industrial call buyer realizes 150% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$143.66

-0.23 (-0.16%)

07:59
08/20/19
08/20
07:59
08/20/19
07:59
Recommendations
Salesforce analyst commentary  »

Salesforce sets up for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:57
08/20/19
08/20
07:57
08/20/19
07:57
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$61.34

0.14 (0.23%)

07:55
08/20/19
08/20
07:55
08/20/19
07:55
Downgrade
Vornado rating change  »

Vornado downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

07:55
08/20/19
08/20
07:55
08/20/19
07:55
General news
U.S. chain store sales fell 0.2% in the week ended August 17 »

U.S. chain store sales…

ANAB

AnaptysBio

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Recommendations
AnaptysBio analyst commentary  »

Cantor says AnaptysBio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOVA

Sunnova Energy

$11.13

0.089 (0.81%)

07:53
08/20/19
08/20
07:53
08/20/19
07:53
Initiation
Sunnova Energy initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:50
08/20/19
08/20
07:50
08/20/19
07:50
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

IMMU

Immunomedics

$14.83

-0.11 (-0.74%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Initiation
Immunomedics initiated  »

Cantor Fitzgerald starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

LVS

Las Vegas Sands

$54.67

2.28 (4.35%)

07:49
08/20/19
08/20
07:49
08/20/19
07:49
Downgrade
Las Vegas Sands rating change  »

Las Vegas Sands cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SILK

Silk Road Medical

$40.85

0.28 (0.69%)

07:44
08/20/19
08/20
07:44
08/20/19
07:44
Initiation
Silk Road Medical initiated  »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

IQ

iQIYI

$18.10

1.02 (5.97%)

07:42
08/20/19
08/20
07:42
08/20/19
07:42
Downgrade
iQIYI rating change  »

iQIYI downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$120.16

-4.81 (-3.85%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNET

ChinaNet Online

$1.50

0.135 (9.89%)

07:41
08/20/19
08/20
07:41
08/20/19
07:41
Hot Stocks
ChinaNet CEO says will continue to integrate blockchain, AI tech into products »

CEO Handong Cheng,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$201.74

22.48 (12.54%)

07:37
08/20/19
08/20
07:37
08/20/19
07:37
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

VVUS

VIVUS

$3.46

-0.02 (-0.57%)

07:36
08/20/19
08/20
07:36
08/20/19
07:36
Hot Stocks
VIVUS says study shows addition of Qsymia to LSG surgery improved weight loss »

VIVUS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$125.55

0.73 (0.58%)

07:36
08/20/19
08/20
07:36
08/20/19
07:36
Recommendations
Splunk analyst commentary at Wedbush »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 28

    Aug

  • 15

    Oct

TPIC

TPI Composites

$17.49

-0.2 (-1.13%)

07:35
08/20/19
08/20
07:35
08/20/19
07:35
Upgrade
TPI Composites rating change  »

TPI Composites upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

PVTL

Pivotal Software

$13.85

-0.16 (-1.14%)

07:35
08/20/19
08/20
07:35
08/20/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.